Cargando…
COVID-19: Unanswered questions on immune response and pathogenesis
The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first appeared in Wuhan, China, in December 2019. In these troubled days the scientific community is asking for rapid replies to prevent and combat the emergency. It is generally accepted that only achieving a better...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205667/ https://www.ncbi.nlm.nih.gov/pubmed/32389590 http://dx.doi.org/10.1016/j.jaci.2020.05.001 |
_version_ | 1783530278575144960 |
---|---|
author | Maggi, Enrico Canonica, Giorgio Walter Moretta, Lorenzo |
author_facet | Maggi, Enrico Canonica, Giorgio Walter Moretta, Lorenzo |
author_sort | Maggi, Enrico |
collection | PubMed |
description | The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first appeared in Wuhan, China, in December 2019. In these troubled days the scientific community is asking for rapid replies to prevent and combat the emergency. It is generally accepted that only achieving a better understanding of the interactions between the virus and the host immune response and of the pathogenesis of infection is crucial to identify valid therapeutic tools to control virus entry, replication, and spread as well as to impair its lethal effects. On the basis of recent research progress of severe acute respiratory syndrome coronavirus 2 and the results on previous coronaviruses, in this contribution we underscore some of the main unsolved problems, mostly focusing on pathogenetic aspects and host immunity to the virus. On this basis, we also touch important aspects regarding the immune response in asymptomatic subjects, the immune evasion of severe acute respiratory syndrome coronavirus 2 in severe patients, and differences in disease severity by age and sex. |
format | Online Article Text |
id | pubmed-7205667 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72056672020-05-08 COVID-19: Unanswered questions on immune response and pathogenesis Maggi, Enrico Canonica, Giorgio Walter Moretta, Lorenzo J Allergy Clin Immunol Reviews and Feature Articles The novel coronavirus disease 2019 has rapidly increased in pandemic scale since it first appeared in Wuhan, China, in December 2019. In these troubled days the scientific community is asking for rapid replies to prevent and combat the emergency. It is generally accepted that only achieving a better understanding of the interactions between the virus and the host immune response and of the pathogenesis of infection is crucial to identify valid therapeutic tools to control virus entry, replication, and spread as well as to impair its lethal effects. On the basis of recent research progress of severe acute respiratory syndrome coronavirus 2 and the results on previous coronaviruses, in this contribution we underscore some of the main unsolved problems, mostly focusing on pathogenetic aspects and host immunity to the virus. On this basis, we also touch important aspects regarding the immune response in asymptomatic subjects, the immune evasion of severe acute respiratory syndrome coronavirus 2 in severe patients, and differences in disease severity by age and sex. The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology. 2020-07 2020-05-08 /pmc/articles/PMC7205667/ /pubmed/32389590 http://dx.doi.org/10.1016/j.jaci.2020.05.001 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Reviews and Feature Articles Maggi, Enrico Canonica, Giorgio Walter Moretta, Lorenzo COVID-19: Unanswered questions on immune response and pathogenesis |
title | COVID-19: Unanswered questions on immune response and pathogenesis |
title_full | COVID-19: Unanswered questions on immune response and pathogenesis |
title_fullStr | COVID-19: Unanswered questions on immune response and pathogenesis |
title_full_unstemmed | COVID-19: Unanswered questions on immune response and pathogenesis |
title_short | COVID-19: Unanswered questions on immune response and pathogenesis |
title_sort | covid-19: unanswered questions on immune response and pathogenesis |
topic | Reviews and Feature Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205667/ https://www.ncbi.nlm.nih.gov/pubmed/32389590 http://dx.doi.org/10.1016/j.jaci.2020.05.001 |
work_keys_str_mv | AT maggienrico covid19unansweredquestionsonimmuneresponseandpathogenesis AT canonicagiorgiowalter covid19unansweredquestionsonimmuneresponseandpathogenesis AT morettalorenzo covid19unansweredquestionsonimmuneresponseandpathogenesis |